First tests of new drug in healthy volunteers
NCT ID NCT06395012
Summary
This early-stage study aimed to check if a new drug called LY3985297 is safe and how the body handles it. It involved 140 healthy volunteers who received either the drug or a placebo as a single shot or multiple shots over several months. The main goal was to monitor for side effects and measure how much of the drug gets into the bloodstream and how long it stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CenExel ACT
Anaheim, California, 92801, United States
-
ICON
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.